2022
DOI: 10.1016/j.ygyno.2021.12.015
|View full text |Cite
|
Sign up to set email alerts
|

Clinical impact of low-volume lymph node metastases in early-stage cervical cancer: A comprehensive meta-analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
22
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 31 publications
(22 citation statements)
references
References 46 publications
0
22
0
Order By: Relevance
“… 30 Ultrastaging of SLNs makes it possible to identify micrometastases and isolated tumor cells, although the impact of these findings remains to be demonstrated. 31 , 32 …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“… 30 Ultrastaging of SLNs makes it possible to identify micrometastases and isolated tumor cells, although the impact of these findings remains to be demonstrated. 31 , 32 …”
Section: Discussionmentioning
confidence: 99%
“…In a study of data from the SENTICOL study, 60.5% of detected SLNs were in the external iliac and interiliac basin, while a substantial proportion were in unusual locations, namely 19.6% in the common iliac, 11.8% in the para‐aortic, and 6% in the parametrium 30 . Ultrastaging of SLNs makes it possible to identify micrometastases and isolated tumor cells, although the impact of these findings remains to be demonstrated 31,32 …”
Section: Discussionmentioning
confidence: 99%
“…However, the clinical impact and treatment of low-volume lymph node metastases remain controversial. A meta-analysis by Guani et al (37) concluded that MIC had a negative effect on DFS and OS, while ITC was not significantly associated with DFS or OS. These results indicated that MIC should be considered true metastasis and treated accordingly.…”
Section: Discussionmentioning
confidence: 99%
“…47 The SENTIX trial (Table 2) demonstrated that all sentinel nodes were detected in the pelvic external iliac, interiliac, common iliac and presacral regions. 44 The SENTICOL III trial 49 is a prospective multicentre randomised study comparing disease-free survival and health-related quality of life in patients with negative SLNalone versus patients with negative SLN and pelvic lymphadenectomy. The trial aims to validate the use of SLN biopsy in early-stage cervical cancer, assuming noninferiority of SLN biopsy in terms of disease-free survival and superiority of SLN biopsy in health-related quality of life.…”
Section: Oncological Safetymentioning
confidence: 99%
“…11,44,48 A recent meta-analysis reported survival outcomes comparing women with micrometastases or ITCs and women with micrometastases-only to those with negative nodes. 49 In terms of disease-free survival, the hazard ratio (HR) was 2.6 (95% CI 1.6-4.3) and 4.1 (95% CI 2.7-6.2), respectively 49 and for overall survival, the HR was 5.7 (95% CI 2.8-11.4) and 6.9 (95% CI 2.6-18.8), respectively. 49 This suggests that low-volume metastatic nodal disease appears to have a negative impact on survival in cervical cancer.…”
Section: Oncological Safetymentioning
confidence: 99%